NZW Mouse

Known as: NZW 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1965-2017
024619652017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
MR16-1 is a monoclonal antibody to mouse IL-6 receptor (IL-6R) and a good tool to investigate the involvement of IL-6 in mouse… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The aim of the present study was to determine whether specific inhibition of mitochondrial permeability transition (MPT) by… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
The current view holds that chronic autoimmune diseases are driven by the continuous activation of autoreactive B and T… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
2001
2001
To better understand the morphogenesis of atherosclerotic plaque, we evaluated temporal distribution of leukocytes, macrophages… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
· Background: Ocular diseases caused by neovascularization are among the leading causes of blindness. No specific pharmacological… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1994
1994
NZW rabbits immunised with a mixture of synthetic peptides representing alpha 138-199 of the human acetylcholine receptor (AChR… (More)
Is this relevant?
1989
1989
Scrapie is an infectious neurodegenerative disease caused by unusual pathogens called prions, in which no scrapie-specific… (More)
Is this relevant?
1987
1987
The NZB/NZW F1 hybrid mouse has been reported to contract a disease similar to Sjögren's syndrome in man. We studied lacrimal… (More)
Is this relevant?
1983
1983
The effect of the immunosuppressive agent cyclosporin A (Cy A) on the renal injury in acute serum sickness was examined in… (More)
Is this relevant?
1977
1977
NZB/NZW F1 hybrid mice were treated with pharmacologic doses of prostaglandin E1 (PGE1) (200 microng subcutaneously either once… (More)
Is this relevant?